首页> 外文期刊>Bone >Novel mutations of CYP27B1 gene lead to reduced activity of 1α-hydroxylase in Chinese patients
【24h】

Novel mutations of CYP27B1 gene lead to reduced activity of 1α-hydroxylase in Chinese patients

机译:CYP27B1基因的新突变导致中国患者1α-羟化酶活性降低

获取原文
获取原文并翻译 | 示例
           

摘要

Pseudovitamin D-deficiency rickets (PDDR) is an autosomal recessive disorder resulting from a defect in renal 25-hydroxyvitamin D 1α-hydroxylase, the key enzyme in the pathway of vitamin D metabolism. We identified ten different mutations in the 1α-hydroxylase gene (CYP27B1) in eight Chinese families with PDDR by DNA-sequence analysis. Six of them are novel missense mutations: G57V, G73W, L333F, R432C, R459C, and R492W; three are novel deletion mutations: c48-60del, c1310delG, and c1446delA; and an insertion mutation c1325-1332insCCCACCC reported previously. Functional assay revealed that the missense mutants identified in this study retain 5.5-12.1% 1α-hydroxylase activity of the wild type. The study describes nine novel mutations in addition to 37 known mutations of CYP27B1 gene and shows the correlation between these mutations and the clinical findings of 1α-hydroxylase deficiency.
机译:伪维生素D缺乏性病(PDDR)是一种常染色体隐性遗传疾病,由肾脏25-羟基维生素D1α-羟化酶(维生素D代谢途径中的关键酶)缺陷引起。通过DNA序列分析,我们确定了八个中国PDDR家族中1α-羟化酶基因(CYP27B1)的十种不同突变。其中六个是新的错义突变:G57V,G73W,L333F,R432C,R459C和R492W;三个是新的缺失突变:c48-60del,c1310delG和c1446delA;先前报道了插入突变c1325-1332insCCCACCC。功能测定表明,该研究中鉴定的错义突变体保留了野生型的5.5-12.1%1α-羟化酶活性。该研究描述了除CYP27B1基因的37个已知突变外的9个新突变,并显示了这些突变与1α-羟化酶缺乏症的临床发现之间的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号